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ABSTRACT
An oenological strain of Saccharomyces cerevisiae was previously shown to produce a 5–10 kDa peptidic fraction responsible
for the inhibition of malolactic fermentation (MLF). In the present study, we aim to further purify the anti-MLF peptides of
this fraction. The yeast fermented synthetic grape juice medium was fractionated by ammonium sulfate precipitation
combined with ultrafiltration. The 5–10 kDa fraction recovered at a saturation degree of 60%–80% was the only fraction that
inhibited both the bacterial growth and the malate consumption in vivo. It also inhibited the malolactic enzyme activity in
vitro at a pH range between 3.5 and 6.7. Therefore, it was purified by both anion and cation exchange chromatography. The
eluates that inhibited the malolactic enzyme activity in vitro were migrated on Tricine SDS-PAGE and the protein bands
were excised and sequenced by LC-MS/MS. The sequencing revealed nine peptides originating from eight proteins of S.
cerevisiae. Two GAPDH cationic fragments of 0.9 and 1.373 kDa having a pI of 10.5 and 11 respectively, Wtm2p and Utr2p
anionic fragments of 2.42 kDa with a pI of 3.5 and 4 respectively were thought to contribute the most to the MLF inhibition.
Keywords: malolactic fermentation (MLF); anti-MLF yeast peptides; Wtm2p; Utr2p; glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)
INTRODUCTION
Antimicrobial peptides (AMPs) play an important role in the in-
nate immune system of eukaryotes against virulent bacteria,
viruses and fungi (Wong, Xia andNg 2007; Sang and Blecha 2009).
The majority of AMPs are cationic in nature and kill microbes
by interacting with the negatively charged components of the
cell-wall and/or plasma membrane (Brogden 2005). However,
many anionic AMPs have also been found to be involved in the
defensemechanisms (Harris, Dennison and Phoenix 2009). The ac-
tivity of anionic AMPs can be enhanced either by divalent metal
cations such as Fe++, Mn++ and Mg++ that facilitate their bind-
ing to anionic membrane components (Dashper et al. 2005), or
by the aggregation of several peptides (Nissen-Meyer et al. 1992).
Some AMPs are able to translocate across the membrane of sen-
sitive cells or increase the membrane permeability by forming
pores (Harris, Dennison and Phoenix 2009), while others have been
found to induce apoptosis in sensitive cells. For example, killer
strains of Saccharomyces cerevisiae that produce killer toxins K1
and K28, induce apoptosis in sensitive yeast cells (Reiter et al.
2005). Besides, bacteriocins produced by some strains of Gram
positive bacteria are either bacteriostatic or bactericidal, against
a wide range of pathogenic and spoilage bacteria. Some of them
like nisin are already used as biopreservatives in different food
sectors such as the dairy industry; however, their use in thewine
sector is still prohibited. Pediocin PD-1 produced by Pediococcus
damnosusNCFB 1832, was able to killOenococcus oeni and outcom-
pete nisin (Nel et al. 2002).
In winemaking, several AMPs were found to be responsible
for the inhibition ofmalolactic fermentation (MLF). These AMPs,
produced by different strains of S. cerevisiae, were partially pu-
rified, and assumptions about their mechanism of action were
given but the results were not conclusive. Most of the time, the
peptides were considered to target the plasma membrane of O.
oeni, resulting in the inhibition of the bacterial growth and con-
sequently themalate consumption (Comitini et al. 2005; Osborne
and Edwards 2007). TheAMPs found byMendoza,Manca de Nadra
and Farias (2010) inhibited the bacterial growth only. Branco et al.
(2014) were the first to identify the nature of the AMPs produced
by S. cerevisiae CCMI 885. These AMPs were active against sev-
eral non-Saccharomyces yeasts and one strain of O. oeni. They
corresponded to two fragments of the C-terminal amino acid
sequence of the S. cerevisiae GAPDH isoenzymes (GAPDH 2/3
of 1.638 kDa and GAPDH1 of 1.622 kDa, pI of 4.37). Recently,
Branco et al. (2017) found that these AMPs were also produced by
other strains of S. cerevisiae but at different concentrations. The
GAPDH peptidic fragments disturbed the plasma membranes of
sensitive yeast cells and increased their permeability. They were
able to enter the cytoplasm and trigger apoptosis. However, the
experiments were only conducted on yeasts and not on O. oeni.
Nehme, Mathieu and Taillandier (2010) demonstrated that S.
cerevisiaeUvafermBDX released a 5–10 kDa peptidic fraction that
strongly inhibited the growth and the malate consumption dur-
ing the MLF performed by O. oeni Vitilactic F. Later on, Rizk et al.
(2016) showed that this fraction was gradually released during
alcoholic fermentation (AF) and reached its highest concentra-
tion at late stages of the stationary phase (120 h). It was able to
directly inhibit the malolactic enzyme activity in vitro at a pH
range between 3.5 and 6.7. Rizk et al. (2016) were the first re-
searchers to demonstrate that AMPs can inhibit the malate con-
sumption by directly inhibiting the malolactic reaction. These
results suggest that in vivo the peptides would enter the cells by
mechanisms yet to be identified in order to inhibit MLF. Since
MLF is one of the main energy sources during winemaking, the
inhibition of the bacterial growth can be a consequence of the
MLF inhibition. Rizk et al. (2016) also showed that the same pair-
ing (S. cerevisiae Uvaferm BDX/O. oeni Vitilactic F) maintained the
MLF inhibition in Cabernet Sauvignon and Syrah wines.
In the present work, we intend to further purify the AMPs
of the 5–10 kDa peptidic fraction in order to identify their na-
ture and to better understand their mechanism of action. The
synthetic grape juice (SGJ) medium fermented by S. cerevisiae
Uvaferm BDX is fractionated by ammonium sulfate precipita-
tion combined with ultrafiltration. Then, the peptidic fraction
responsible for the MLF inhibition in vivo and in vitro experi-
ments is purified by ion exchange chromatography (both an-
ion and cation) followed by SDS-PAGE. Finally, the peptides of
interest are sequenced by LC-MS/MS and characterized regard-
ing their amino acid sequence, molecular weight, theoretical pI,
the yeast proteins from which they derive and their putative
mechanisms of action.
MATERIALS AND METHODS
All culture media components were supplied by Sigma–Aldrich
(Taufkirchen-Germany) except for the yeast extract and the pep-
tone that were supplied by Oxoid (Hampshire-England). The Au-
rum ion exchange mini kits and columns and the chemicals
used for SDS-PAGE were purchased from Bio-Rad (California,
USA).
Strains and storage conditions
Saccharomyces cerevisiae Uvaferm BDX, Lalvin CY3079 and O. oeni
Vitilactic F used in this work were kindly provided by Lallemand
Inc. (Blagnac, France). Yeast stock cultures were kept at 4◦C in
YEPD (Yeast Extract Peptone Dextrose) agar slants composed of
10 g L−1 Yeast Extract, 20 g L−1 peptone, 20 g L−1 D-glucose and 20
g L−1 agar. The bacterial strain was kept frozen at –20◦C in MRS
(De Man, Rogosa and Sharpe) broth containing 20% glycerol (v/v).
Growth media
SGJ medium
The SGJ medium that simulated the natural grape juice con-
sisted of: D-glucose 100 g L−1, D-fructose 100 g L−1, Yeast Extract
1 g L−1, (NH4)2SO4 2 g L−1, citric acid 0.3 g L−1, L-malic acid 3 g
L−1, L-tartaric acid 5 g L−1, MgSO4 0.4 g L−1 and KH2PO4 5 g L−1,
pH adjusted to 3.5 using a 10MNaOH solution. Themediumwas
autoclaved before use (121◦C, 20 min).
Modified MRS medium
The MRS medium was supplemented with L-malic acid (3 g L−1)
and Tween 80 (1 mL). After autoclaving (121◦C, 15 min), 10%
ethanol (v/v) were aseptically added through sterile filter mem-
branes of 0.22 μm cut-off (Elvetec services, Meyzieu-France) and
the pH was adjusted to 3.5 using an 85% orthophosphoric acid
solution.
Alcoholic fermentation
The SGJ media were inoculated either with S. cerevisiae Uvaferm
BDX orwith S. cerevisiae Lalvin CY3079 at an initial concentration
of 3× 106 cellsmL−1 (Thoma counting chamber). The AFwas fol-
lowed until total or cessation of sugar consumption (<2 g L−1).
The yeast inoculumwas beforehand prepared in two steps. First,
a pre-culture of the yeast strain was obtained by reactivating
the stock culture in YEPD broth for 24 h. Second, the pre-culture
was used to inoculate a low sugar concentration SGJ medium:
D-Glucose 50 g L−1 and absence of D-Fructose. This step was car-
ried out for 24 h and provided the yeast inoculum. All fermen-
tation steps were carried out at 22◦C with stirring at 150 rpm in
Erlenmeyer flasks.
AFs were performed in three independent replicates.
Fractionation of yeast fermented media by ammonium sulfate pre-
cipitation combined with ultrafiltration
After completion of the AF (120 h), yeast cells were removed by
centrifugation (3500 rpm, 20 min at 4◦C) and 500 mL of the su-
pernatant were recuperated. The amounts of solid ammonium
sulfate added to the supernatant were calculated according
to the program [www.encorbio.com/protocols/AM SO4.htm] in
order to reach the following saturation percentages: A: 0%–20%,
B: 20%–40%, C: 40%–60%, D: 60%–80% and E: 80%–100%.
For each saturation level, the salt was added gradually to
the supernatant for 1 h while shaking at 4◦C. 90 min later, the
medium was centrifuged at 5000 rpm for 30 min at 4◦C. After
centrifugation, the protein pellet was recovered and suspended
in 10 mL of a phosphate buffer (0.1 M, pH 6.7). This resulted
in samples that were 50 times more concentrated (50×). After-
wards, the sample was fractionated through a centrifugal fil-
ter unit presenting a cut-off of 10 kDa (Amicon R© Ultra-15 with
ultracel-10 membrane) at 3500 g for 45 min at 4◦C. The filtrate
with a MW ≤10 kDa was recovered and ultrafiltered again us-
ing a centrifugal filter unit of 5 kDa cut-off (Corning R© Spin-X UF
20 Sigma-Aldrich). A desalted protein retentate of 0.2 mL with a
MW between 5 and 10 kDa was then recovered. The ultrafiltra-
tion added a new concentration factor of 50×. The protein reten-
tate (2500×) was added to 20 mL of a modified MRS medium in
order to evaluate any potential effect on MLF. It was 100 times
diluted and was finally 25 times concentrated in the MRS broth.
The remaining supernatant was used again to reach a new
saturation level and the same procedure was applied. The im-
pact of the five precipitated fractions (A, B, C, D and E) on MLF
was evaluated separately in modified MRS media, inoculated
with 2 × 106 cells mL−1 (Petroff-Hausser counting chamber) of O.
oeni Vitilactic F corresponding to an initial bacterial biomass of
0.0016 g L−1. The bacterial inoculumwas beforehand prepared in
two steps. A pre-culture was obtained by reactivating the stock
culture in MRS broth, with 3% ethanol (v/v) added. After 24 h,
the pre-culture was used to inoculate another MRS broth with
6% ethanol (v/v) added. The latter provided the bacterial inocu-
lumafter an incubation period of 24 h. All the fermentation steps
were performed at 22◦C with stirring at 150 rpm.
Both bacterial growth and malate consumption were fol-
lowed by regular sampling until cessation of malate consump-
tion and were compared to those of a modified MRS control.
All the experiments were performed in three independent
replicates.
Protein purification by Aurum ion exchange mini kits and columns
Aurum anion exchange (AEX) and cation exchange (CEX)
columns allowed rapid fractionation of complex protein mix-
tures in only a few steps using the common technique of
ion exchange chromatography. Each Aurum AEX (732–6706)
or CEX (732–6703) column contained 0.2 mL of UNOsphere Q
[−N+(CH3)3] or S [−SO3−] support. The buffers selected were the
following:
- Binding buffers: 20 mM phosphate pH 6.7 for CEX and 20 mM
Tris pH 8.3 for AEX
- Elution buffers: binding buffer +0.5 M NaCl or 1 M NaCl
For each analysis, 1 mL (5 × 0.2 mL) of the peptidic frac-
tion (2500×), collected in its appropriate binding buffer, was fil-
tered through a 0.45 μm syringe filter, loaded onto the column,
and gravity filtered. The column placed in a collection tube, was
then washed with 0.9 mL of the appropriate Aurum AEX or CEX
binding buffer, and was centrifuged for 20 sec at 1000 g in a
microcentrifuge. The aim of this step was to properly bind the
sample. The eluate obtained, also called ‘unbound fraction’ was
recovered. Next, the columnwas placed in a new 2mL collection
tube, and 0.3 mL of the appropriate Aurum AEX or CEX elution
buffer containing 0.5 M NaCl were added to the top of the col-
umn before centrifugation at 1000 g for 10 sec. The elution step
Table 1. Reactionmixture for themonitoring of the L-malic acid con-
sumption in vitro at different pH values with or without the peptidic
fractions.
Aliquot 1 (Control) Aliquot 2 (Test) Amounts
Cell-free enzymatic
extract
Cell-free enzymatic
extract
1 mL
Mn++ Mn++ 0.1 mg
NAD+ (35 g L−1) NAD+ (35 g L−1) 0.1 mL
a buffer bAMPs 0.14 mL
L-malic acid (1 g L−1) L-malic acid (1 g L−1) 1 mg
abuffer: 0.1 M of citrate buffer pH 3.5, phosphate buffer pH 6 or phosphate buffer
pH 6.7.
bAMPs: antimicrobial peptides of the peptidic fractions tested.
was repeated twice and the eluate was recovered (eluate 1). Fi-
nally, the column was placed in a new 2 mL collection tube and
washedwith 0.3mL of the AurumAEX or CEX elution buffer con-
taining 1 MNaCl. It was then centrifuged for 10 sec at 1000 g and
the eluate was recovered (eluate 2).
All the experiments were performed in three independent
replicates.
In vitro evaluation of the peptidic fractions effect on the malolactic
enzyme activity
This method was implemented and fully described by Rizk et al.
(2016). It consisted of preparing a cell-free enzymatic extract
containing the malolactic enzyme of O. oeni Vitilactic F. The en-
zymatic extract was recovered in 2mL of a buffer (0.1M of citrate
buffer pH 3.5, phosphate buffer pH 6 or phosphate buffer pH 6.7).
2 mL buffer was divided into two aliquots of 1 mL each. One was
used as a control and the other as a test medium to which the
peptidic fractions were added. The reaction mixture is given in
Table 1. The reagents were added to each aliquot in the order
listed in Table 1. The enzymatic reaction was performed at 30◦C
for 70 min at pH 3.5, 30 min at pH 6 and 40 min at pH 6.7.
At the end of each assay, the concentrations of the L-malic
acid consumed and the L-lactic acid produced were measured
in both aliquots (control and test) and compared.
The effect of each peptidic fraction on themalolactic enzyme
activity was tested in three independent replicates.
Protein analysis by Tricine SDS-PAGE
The peptidic fractions were analyzed by Tricine SDS-PAGE as de-
scribed by Scha¨gger and von Jagow (1987) and Scha¨gger (2006),
to separate proteins on the basis of their molecular sizes. A
trichloroacetic acid solution or TCA solution (20% TCA, 0.2%DTT
in ice-cold acetone −20 ◦C, Bio-Rad) was used for protein precip-
itation. For each sample of 1 mL, 250 μL of TCA solution were
added and the samples were dried in a dry heat block (Major
Science, USA) for 15 min. Proteins were then pelleted (14 000 g,
4◦C, 15min), washed twice in 200μL of ice-cold acetone (14 000 g,
4◦C, 5 min) and suspended in 100 μL of Triton X-100 buffer (2%
Triton X-100, 1% DTT, Sigma-Aldrich). Electrophoresis was car-
ried out using ready-to-use [8%–16%] Mini-PROTEAN R© TGX pre-
cast gels composed of 12 wells in a Mini-PROTEAN R© Tetracell
(Bio-Rad). 20 μL of concentrated samples (10×) were run against
10 μL precision plus protein Dual-Xtra standard (2–250 kDa, cri-
terion 10%–20% Tris-Tricine) composed of 12 recombinant pro-
teins (Bio-Rad) at 100 V for 15 min. Gels were stained using ei-
ther Bio-safe Coomassie G-250 stain or Silver stain kit (Bio-Rad).
Imaging and documentation were done by using the GelDoc XR+
system, controlled by Image Lab software (Bio-Rad).
Peptides sequencing by LC-MS/MS (LC1D-nanoESI-LTQ-Velos
Orbitrap)
The sequencing was contracted out to PAIB2 (Plate-forme
d’Analyse Inte´grative des Biomole´cules Phe´nomiques des Ani-
maux d’Inte´reˆt Bio-agronomique), Laboratoire de Spectrome´trie
deMasse, Centre de Recherches INRA Val de Loire-Tours, France.
The protein bands were first excised from SDS-PAGE and sub-
mitted to in-gel tryptic digestion. The peptidic extract was then
dehydrated and analyzed by using high resolution mass spec-
trometry. The peptides derived from the digestion of the bands
were analyzed by a nano UHPLC Ultimate 3000 RSLC system
(Thermo Electron, Waltham-Massachusetts, USA) coupled with
a high resolution mass spectrometer LTQ Orbitrap Velos ETD
(Thermo Electron). The sampleswere desalted and concentrated
in line by a precolumn Acclaim PepMap100 C18 trap (3 μm,
100 μm × 2 cm) (Dionex, California, USA), then separated on an
analytical reverse phase columnAcclaim PepMap 100 C18 (2 μm,
75μm× 50 cm) (Dionex) with a flow rate of 300μLmin−1. The col-
umn was equilibrated with 96% of solvent A (0.1% formic acid,
2% acetonitrile, 97.9% water) and 4% of solvent B (0.1% formic
acid, 80% acetonitrile, 19.9% water) with a gradient of 4% to 55%
B for 90 min, followed by 99% B for 10 min.
The data acquisition was performed automatically between
high resolution MS modes (R = 60 000) and low resolution frag-
mentation MS/MS. An enhanced centroid full scan (m/z 400–
1800) was followed by MS/MS centroid scans of the 20 most in-
tense peaks detected (qz 0.25, activation time 10 ms, collision
energy 35%). The dynamic exclusion was turned on for 30 sec
with a repeat count of 1.
The data were converted into Mascot Generic file format
(mgf) using Proteome discoverer 1.3 software. It was then com-
pared to the database through Mascot/PD Deamon 2.3 soft-
ware by taking into consideration the following criteria: NCBI
nr database; trypsin and no enzyme; 2 miscleavages; 5 ppm
mass accuracy for MS and 0.8 Da for MS/MS; peptide load 2 and
3+; carbamidomethylation of cysteine; N-terminal acetylation;
oxidation of methionine; data format: mgf; decoy database; in-
strument: ESI-FTICR; taxonomy: Saccharomyces cerevisiae .
The peptides and proteins identified by theMascot search en-
gine were validated by the Peptide Prophet and Protein Prophet
algorithms using Scaffold 4 software.
Determination of the protein concentration by the Lowry method
Protein concentration was determined using the Lowry method
as described by Frolund, Griebe and Nielsen (1995). Results were
determined according to a BSA standard curve and expressed in
mg L−1.
Determination of the L-malic acid concentration
The L-malic acid concentration was determined using an enzy-
matic assay (Boehringer Mannheim/R-Biopharm, kit. No 10 139
068 035, Darmstadt-Germany) and the results were expressed in
g L−1.
Determination of the L-lactic acid concentration
The L-lactic acid concentration was determined using an enzy-
matic assay (Boehringer Mannheim/R-Biopharm, kit. No 10 139
084 035, Darmstadt-Germany) and the results were expressed in
g L−1.
Determination of the bacterial biomass
The biomass (dry weight) was determined using a thermobal-
ance or moisture analyzer (Ohaus-UK). A correlation between
the bacterial cell concentration (cells mL−1) and the bacterial
biomass (g L−1) was established using high bacterial concentra-
tions in modified MRS media. The correlation obtained was the
following:
y(gL−1) = 8.10−10 x (cells mL−1).
It was then used to determine the biomass of low concentrated
samples.
Statistical analyses
Means and standard deviations of the assayswere calculated us-
ing conventional statistical methods. Each experiment was per-
formed in three replicates. The statistical analysis was carried
out using XLSTAT 2014.5 for MS Excel.
RESULTS
Fractionation of the SGJ medium fermented by
S. cerevisiae Uvaferm BDX by ammonium sulfate
precipitation combined with ultrafiltration
The SGJ medium fermented by S. cerevisiae Uvaferm BDX was
fractionated by ammonium sulfate precipitation combined with
ultrafiltration. A 5–10 kDa peptidic fraction was recovered from
each ammonium sulfate precipitate (A: 0%–20%, B: 20%–40%, C:
40%–60%, D: 60%–80% and E: 80%–100%). The effect of each pep-
tidic fraction on MLF was evaluated separately in a modified
MRSmedium inoculated with O. oeni Vitilactic F. This choice was
made because it was previously shown that S. cerevisiaeUvaferm
BDX was able to produce and release a peptidic fraction with an
apparent MW between 5 and 10 kDa that strongly inhibited O.
oeni Vitilactic F (Nehme, Mathieu and Taillandier 2010; Rizk et al.
2016). In the previous works, the peptidic fraction was recovered
by ultrafiltration whereas in this paper, the ammonium sulfate
precipitation was combined with ultrafiltration in order to fur-
ther reduce the amount of peptides and easily select the anti-
MLF ones.
Fig. 1 shows that neither the growth nor the malate con-
sumption were affected by the 80%–100% precipitate and the ki-
netics were similar to those of the control. However, the 0%–20%,
20%–40% and 40%–60% precipitates strongly inhibited the bacte-
rial growth with no effect on themalate consumption. The 60%–
80% precipitatewas the only one that strongly inhibited both the
bacterial growth and the malate consumption. Its protein con-
centration was the highest (650 mg L−1); 2.54 times higher than
that of the other precipitates (data not shown).
The same work was carried out with the SGJ medium fer-
mented by S. cerevisiae Lalvin CY3079 that is a non-inhibitory
strain (Nehme,Mathieu and Taillandier 2008). The results obtained
with all the precipitates were similar to those of the modified
MRS control, showing no inhibition, neither on the bacterial
growth nor on themalate consumption (data not shown). There-
fore, S. cerevisiae Lalvin CY3079 was used as a reference strain in
this study.
In vitro evaluation of the malolactic enzyme inhibition
by the 5–10 kDa peptidic fraction of the 60%–80%
ammonium sulfate precipitate
In this experiment, themalolactic enzyme of the cell-free bacte-
rial enzymatic extract was directly exposed to the peptidic frac-
tions. The protein concentration of all the enzymatic extracts
Figure 1. Growth (A) and malic acid consumption (B) kinetics of O. oeni Vitilactic
F in the presence of the 5–10 kDa peptidic fractions of the ammonium sulfate
precipitates obtained from the SGJ medium fermented by S. cerevisiae Uvaferm
BDX. () Control: modified MRS medium without peptidic fractions; modified
MRS medium with 5–10 kDa fractions collected at different saturation degrees:
(x) 0%–20%, () 20%–40%, (•) 40%–60%, () 60%–80%, (©) 80%–100%. Each value
is the mean of triplicate experiments ± SD.
prepared wasmeasured before addition of the peptidic fractions
and was approximately the same with an average value of 302.2
(± 20) mg L−1. pH 3.5 was chosen because all the MLFs of this
study were carried out at this pH value. pH 6 was used because
it is the optimum pH for the malolactic enzyme activity of O.
oeni and pH 6.7 is around the cytoplasmic pH of the majority
of lactic acid bacteria. Table 2 shows that the 5–10 kDa peptidic
fraction of the 60%–80% ammonium sulfate precipitate obtained
from S. cerevisiae Uvaferm BDX was able to inhibit the malate
consumption by directly targeting the malolactic enzyme ac-
tivity at all the pH values tested. For instance, at pH 6.7, the
malate consumption was reduced by 99% in comparison to the
control. The 0%–20% precipitate was used as an additional con-
trol since it only inhibited the bacterial growth in the modified
MRS medium and not the malate consumption (Fig. 1). Table 2
also shows that this precipitate did not affect the malolactic en-
zyme activity in vitro. Additionally, the 5–10 kDa fraction of the
60%–80% precipitate isolated from the SGJ medium fermented
by S. cerevisiae Lalvin CY3079 (reference strain or non-inhibitory
strain), was tested and gave results identical to the control. In
terms of specific malolactic activities, the highest value (0.1 g
L−1 of L-malic acid consumed/min/mg of proteins) was obtained
at pH 6 in the absence of inhibition. It was 1.37 and 2.33 times
higher than those obtained at pH 6.7 and 3.5 respectively. How-
ever, in the presence of the inhibitory fraction (5–10 kDa of the
60%–80% precipitate from Uvaferm BDX), the specific activities
were almost null at all the pH values tested (Table 3).
The amounts of L-lactic acid produced were measured and
found to be stoichiometrically equivalent to the amounts of L-
malic acid consumed. This is an additional proof that the in-
hibitory peptidic fraction targeted specifically themalolactic en-
zyme of the enzymatic extract.
Altogether, it can be concluded that the inhibition of themal-
olactic enzyme by the 5–10 kDa peptidic fraction of the 60%–80%
ammonium sulfate precipitate of S. cerevisiae Uvaferm BDX was
highly specific. Therefore, it was retained for further purifica-
tion.
Comparison of the protein profiles of S. cerevisiae
Uvaferm BDX and Lalvin CY3079 by Tricine SDS-PAGE
The 5–10 kDa peptidic fractions of the 60%–80% ammonium sul-
fate precipitates obtained from the SGJmedia fermented by both
strains of S. cerevisiae were analyzed and compared by Tricine
SDS-PAGE. The results are given in Fig. 2. Tricine SDS-PAGE anal-
ysis of the inhibitory fraction released by S. cerevisiae Uvaferm
BDX, revealed three protein bands with an apparent MW of
Table 2. Consumed L-malic acid (g L−1) and produced L-lactic acid (g L−1) during the enzymatic reaction in vitro performed at different pH values
in the presence of peptidic fractions isolated from the SGJ media fermented by S. cerevisiae Uvaferm BDX and Lalvin CY3079.
pH = 6.7 bt = 40 min pH = 6 bt = 30 min pH = 3.5 bt = 70 min
Consumed
L-malic acid
(g L−1)
Produced
L-lactic acid
(g L−1)
Consumed
L-malic acid
(g L−1)
Produced
L-lactic acid
(g L−1)
Consumed
L-malic acid
(g L−1)
Produced
L-lactic acid
(g L−1)
Control (absence of
aAMPs)
1.00 (±0.02) 0.670 (±0.013) 0.933 (±0.020) 0.620 (±0.001) 0.974 (±0.002) 0.65 (±0.01)
5–10 kDa fraction of the
60%–80% precipitate
from Uvaferm BDX
0.0080
(±0.0002)
0.0053
(±0.0001)
0.0012 (±0) 0.0080
(±0.0002)
0.0090
(±0.0002)
0.0060 (±0.0001)
5–10 kDa fraction of the
0%–20% precipitate
from Uvaferm BDX
0.90 (±0.02) 0.60 (±0.01) 0.90 (±0.02) 0.60 (±0.01) 1.00 (±0.02) 0.67 (±0.01)
5–10 kDa fraction of the
60%–80% precipitate
from Lalvin CY3079
0.94 (±0.02) 0.620 (±0.001) 1.00 (±0.02) 0.620 (±0.001) 0.98 (±0.02) 0.650 (±0.001)
aAMPs: antimicrobial peptides of the peptidic fractions tested.
bt = 40 min, t = 30 min and t = 70 min: incubation time required for the total conversion of L-malic acid (1 g L−1) into L-lactic acid and CO2 during the malolactic
reaction in vitro in the control aliquot at the different pH values tested.
Table 3. Specificmalolactic activities of the enzymatic reactions in vitro calculated in the controls and in the presence of different yeast peptidic
fractions.
b Specific malolactic activities (g L−1 of L-malic acid
consumed/min/mg of proteins)
pH 6.7 pH 6 pH 3.5
Control (absence of aAMPs) 0.08 0.1 0.05
5–10 kDa fraction of the 0%–20% precipitate from Uvaferm BDX 0.07 0.09 0.04
5–10 kDa fraction of the 60%–80% precipitate from Lalvin CY3079 0.07 0.1 0.04
Average specific malolactic activities in the absence of inhibition 0.073 (±0.006) 0.1 (±0.006) 0.043 (±0.006)
5–10 kDa fraction of the 60%–80% precipitate from Uvaferm BDX 0.0005 0.0001 0.0003
aAMPs: antimicrobial peptides of the peptidic fractions tested.
bSpecific malolactic activities are calculated by dividing the amount of L-malic acid consumed (g L−1) by the duration of the enzymatic reaction (min) and by the
amount of proteins present in the enzymatic mixture (mg).
The different amounts of proteins are: 0.302 mg in the controls; 0.338 mg in the presence of the 0%–20% precipitate from Uvaferm BDX, 0.349 mg in the presence of
the 60%–80% precipitate from Lalvin CY3079 and 0.393 mg in the presence of the 60%–80% precipitate from Uvaferm BDX.
Figure 2. Silver stained Tricine SDS-PAGE gel. LaneA corresponds to the dual-xtra
MW standard 2–250 kDa (Bio-Rad). Lane B corresponds to the 5–10 kDa fraction
of the 60%–80% precipitate of S. cerevisiae Uvaferm BDX. Lane C corresponds to
the 5–10 kDa fraction of the 60%–80% precipitate of S. cerevisiae Lalvin CY3079
(reference strain).
approximately 5.1 kDa (1), 7.2 kDa (2) and 8.4 kDa (3) as shown in
lane B. Two of these protein bands, (1) and (2), were not present
in the SGJmedium fermented by Lalvin CY3079 (lane C). Besides,
band (3) of approximately 8.4 kDa was released by both strains,
but was more concentrated in the SGJ medium fermented by
Uvaferm BDX. Therefore, it is likely that the peptides of these
bands were involved in the MLF inhibition. The use of Lalvin
CY3079 strain as a reference strain was helpful since the com-
parison of the protein profiles proved that strain Uvaferm BDX
was able to produce additional peptides.
Fractionation of the 5–10 kDa peptidic fractions of the
60%–80% ammonium sulfate precipitates by anion and
cation exchange chromatography and evaluation of the
inhibitory effect of the eluates on the malolactic
enzyme activity in vitro
In order to further reduce the amount of peptides and specif-
ically target the anti-MLF ones, the 5–10 kDa peptidic fraction
Table 4. Consumed L-malic acid (g L−1) and produced L-lactic acid (g
L−1) in the controls and in the presence of the eluates obtained from
AEXC and CEXC.
pH = 6.7; t = 40 min
Consumed
L-malic acid
(g L−1)
Produced
L-lactic acid
(g L−1)
aControl 1 0.98 (±0.02) 0.66 (±0.01)
bControl 2 1.00 (±0.02) 0.68 (±0.01)
cControl 3 1.00 (±0.02) 0.68 (±0.01)
dUnbound fraction 0.96 (±0.02) 0.64 (±0.01)
Eluate 1 from AEXC (0.5 M NaCl) 0.002 (±0) 0.0013 (±0)
Eluate 1 from CEXC (0.5 M NaCl) 0.002 (±0) 0.0013 (±0)
Eluate 2 from AEXC (1 M NaCl) 0.96 (±0.02) 0.65 (±0.01)
Eluate 2 from CEXC (1 M NaCl) 0.97 (±0.02) 0.67 (±0.01)
aControl 1: 0.14 mL of phosphate buffer 0.1 M pH 6.7 were added instead of the
peptidic eluate.
bControl 2: 0.14 mL of NaCl 0.5 M were added instead of the peptidic eluate.
cControl 3: 0.14 mL of NaCl 1 M were added instead of the peptidic eluate.
dUnbound fraction: 0.14 mL of the fraction that was not retained on the column
after sample binding in AEXC or CEXC.
of the 60%–80% ammonium sulfate precipitate of S. cerevisiae
Uvaferm BDX was analyzed by ion exchange chromatography.
The eluates from both anion and cation exchange chromatogra-
phy (AEXC and CEXC) were tested in vitro in the presence of the
malolactic enzyme of the cell-free enzymatic extract.
Control 1 in Table 4 is the usual control used in all the in vitro
experiments. It enables us tomonitor themalolactic enzyme ac-
tivity in vitro. Controls 2 and 3 were added to this experiment to
evaluate the effect of NaCl on the malolactic enzyme activity.
In fact, the elution of peptides in both AEXC and CEXC was per-
formed using increasing concentrations of NaCl (0.5 M then 1 M
of NaCl) in the elution buffers. We wanted to make sure that the
inhibition observed in the presence of the eluates was only due
to the peptides and not to the NaCl. The results show that the
presence of NaCl did not affect the malolactic enzyme activity
since the 1 g L−1 of L-malic acid initially present in the control
aliquots (controls 2 and 3) was totally consumed. The unbound
fraction corresponds to the fraction that was not retained on the
column after loading and binding the sample. It did not inhibit
the malolactic enzyme activity as shown in Table 4. Therefore,
it did not contain any inhibitory peptide. Its analysis underlines
the effectiveness of this purification step.
Figure 3. Coomassie G-250 stained Tricine SDS-PAGE gel. Lane A contains dual-
xtra MW standard 2–250 kDa (Bio-Rad). Lane B corresponds to eluate one from
CEXC. Lane C corresponds to eluate one from AEXC.
Eluates obtained after elution with 0.5 M NaCl from both
AEXC andCEXC (eluates 1 of Table 4) strongly inhibited themalo-
lactic enzyme activity since only 0.2% of themalate presentwere
consumed. However, those eluted with 1M NaCl did not affect
the enzyme’s activity and the malate was entirely consumed.
Therefore the peptides of interest were recuperated in eluates
1 of both AEXC and CEXC. The same procedure was performed
with strain Lalvin CY3079 and none of the eluates showed any
inhibition (data not shown).
Tricine SDS-PAGE analysis of the inhibitory eluates
followed by sequence analysis of the protein bands by
LC-MS/MS
Fig. 3 shows the results obtained aftermigration of the inhibitory
eluates on Tricine SDS-PAGE (eluates one from both AEXC and
CEXC). The cationic eluate gave two protein bands of approxi-
mately 5.1 and 7.2 kDa whereas the anionic eluate gave one pro-
tein band of 5.1 kDa. The three protein bands from both eluates
were excised and sequenced in order to identify the nature of
the putative antibacterial peptides responsible for the MLF inhi-
bition.
Tables 5 and 6 give the nature of the peptides identified by LC-
MS/MS (LC1D-nanoESI-LTQ-Orbitrap) as well as their amino acid
sequence,molecularweight and theoretical isoelectric point (pI).
The cationic eluate revealed 7 protein fragments corresponding
to 6 proteins of S. cerevisiae whereas the anionic eluate revealed
2 protein fragments corresponding to 2 yeast proteins.
DISCUSSION
The current study aims to further purify and identify the pu-
tative anti-MLF peptides of the 5–10 kDa peptidic fraction pro-
duced by S. cerevisiae Uvaferm BDX that inhibited the growth of
O. oeni Vitilactic F and its ability to consume L-malic acid during
sequential fermentations (Nehme, Mathieu and Taillandier 2010;
Rizk et al. 2016). First, the SGJ medium, fermented by S. cerevisiae
Uvaferm BDX, was fractionated by ammonium sulfate precipi-
tation combined with ultrafiltration. The results obtained sug-
gested the presence of two categories of inhibitory proteina-
ceous compounds (Fig. 1). The first one inhibited the growth of
O. oeni Vitilactic F only (5–10 kDa peptidic fractions of the 0%–
60% precipitates), while the second one inhibited both the bac-
terial growth and the malate consumption (5–10 kDa peptidic
fraction of the 60%–80% precipitate). With the latter, the inhi-
bition of the bacterial growth could be a consequence of the
malate consumption inhibition or it could be due to the presence
of both categories of protein compounds. In winemaking condi-
tions, MLF is one of the main energy sources for bacterial sur-
vival and growth (Cox and Henick-Kling 1995; Bouix and Ghor-
bal 2015), thus, an inhibition of themalate consumption can also
cause an inhibition of the bacterial growth.
Second, the 5–10 kDa peptidic fraction of the 60%–80% am-
monium sulfate precipitate was tested in vitro in a cell-free cy-
tosolic extract of O. oeni Vitilactic F containing the malolactic
enzyme. The results of Table 2 show that the peptidic fraction
strongly inhibited the malolactic enzyme activity in vitro at a pH
range between 3.5 and 6.7. Therefore, this fraction is believed
to enter the bacterial cytoplasm in vivo by mechanisms yet to
be identified in order to directly target and inhibit the malolac-
tic enzyme. These results are in accordance with those obtained
by Rizk et al. (2016) who were the first to show that yeast pro-
teinaceous compounds can inhibit MLF by directly targeting the
malolactic enzyme activity.
The 5–10 kDa peptidic fraction of the 60%–80% ammonium
sulfate precipitate was further purified by ion exchange chro-
matography. The anionic and cationic eluates that inhibited the
malolactic enzyme activity in vitro (eluates 1 of Table 4) were mi-
grated by SDS-PAGE and the bands of interest were excised and
sequenced by LC-MS/MS. The cationic eluate revealed 7 protein
fragments corresponding to 6 proteins of S. cerevisiae whereas
the anionic eluate revealed 2 protein fragments corresponding
to 2 yeast proteins. The following identified proteins play di-
verse vital roles in S. cerevisiae cells: the short-chain dehydroge-
nase/reductase protein binds and stabilizes the pre-tRNAs and
RNA polymerase III transcripts (Schenk et al. 2012). Yeast actin
is a structural protein involved in cell polarization, endocyto-
sis, cytoskeleton functions and histone acetyltransferase activ-
ity (Greeber and Schenkman 1982; Moseley and Goode 2006).
YDL025C-like protein is a major protein kinase involved in pro-
tein phosphorylation (Ptacek et al. 2005). Petite colonies protein
or Pet127p is a membrane-associated protein involved in stabil-
ity and processing of S. cerevisiae mitochondrial RNAs (Wiesen-
berger and Fox 1997). Utr2p has a hydrolase activity, hydrolyzing
O-glycosyl compounds (Novo et al. 2009). Wtm1p (WD repeat-
containing transcriptional modulator) is a protein present in a
large nuclear complex and presenting two homologs, Wtm2p
and Wtm3p, which probably arose by gene duplications. These
proteins are transcriptional modulators with roles in meiotic
regulation and silencing and RNR genes expression. They are
also involved in response to replication stress and are relocal-
ized in the cytosol in response to hypoxia (Pemberton and Blobel
1997). Therefore, peptidic fragments of Wtmp are produced and
released by yeasts in response to stress.
There are no previous studies that describe the antimicro-
bial activities of the above mentioned proteins and/or their cor-
responding fragments against bacteria or against fungi.
The sequencing also revealed two peptidic fractions of
GAPDH in the cationic eluate, one having a MW of 0.9 kDa
and a pI of 10.5 while the other presented a MW of 1.373 kDa
and a pI of 11 (Table 5). Branco et al. (2014) previously demon-
strated that GAPDH fragments were involved in the growth
Table 5. Sequence analysis by LC1D-nanoESI-LTQ-Orbitrap of the peptides corresponding to the 5.1 and 7.2 kDa protein bands obtained from
the cationic eluate.
Cationic peptides/proteins
Identified proteins Accession number Sequence of amino acids
Identification
probability
Actual
mass (Da) Start Stop pI
Putative short-chain de-
hydrogenase/reductase
[S. cerevisiae S288c]
gi—6 322 742 (+4) (K)DmAVSYLSR(Y) 100% 1056.49 118 126 9
Actin [S. cerevisiae
S288c]
gi—14 318 479 (+2) (K)AGFAGDDAPR(A) 100% 975.4408 19 28 6.5
Conserved protein [S.
cerevisiae YJM789]
gi—151 944 993 (+1) (S)SAASAGVSR(I) 96% 804.4088 15 23 10.5
Glyceraldehyde-3-
phosphate
dehydrogenase [S.
cerevisiae YJM789]
gi—151 943 468 (+4) (K)KVVITAPSS(T) 99% 900.5276 116 124 10.5
Glyceraldehyde-3-
phosphate
dehydrogenase [S.
cerevisiae YJM789]
gi—151 943 468 (+4) (R)TASGNIIPSSTGAAK(A) 100% 1373.71 199 213 11
YDL025C-like protein [S.
cerevisiae AWRI796]
gi—323 334 240 (+1) (−)mEVVTNHTQR(Q) 97% 1271.60 1 10 7.4
Petite colonies protein
[S. cerevisiae YJM789]
gi—151 944 772 (+1) (K)TNGAASLDPTKER(K) 95% 1358.68 53 65 10.2
Table 6. Sequence analysis by LC1D-nanoESI-LTQ-Orbitrap of the peptides corresponding to the 5.1 kDa protein band obtained from the anionic
eluate.
Anionic peptides/proteins
Identified proteins
Accession
number Sequence of amino acids
Identification
probability
Actual
mass (Da) Start Stop pI
Wtm2p [S. cerevisiae
Lalvin QA23]
gi—323 346 419 (D)DDDDDNDDDDEEGNxKTKSAAT(P) 98% 2420.89 89 110 3.5
Utr2p [S. cerevisiae
EC1118]
gi—259 145 860
(+3)
(F)CNATQACPEDKPCCSQYGEcGTG(Q) 97% 2420.89 27 49 4
inhibition of O. oeni and some non-Saccharomyces yeasts. How-
ever, the two GAPDH fragments identified by these authors were
not the same as those found in the current study. They had
different amino acid sequences that corresponded to two frag-
ments of the C-terminal amino acid sequence of the GAPDH
isoenzymes (GAPDH2/3 with a MW of 1.638 kDa and GAPDH1
with a MW of 1.622, pI of 4.37). Their antibacterial activity
was tested only against the growth and not against the malate
consumption. Branco et al. (2017) demonstrated that several
strains of S. cerevisiaewere able to release the same GAPDH frag-
ments previously identified but at different concentrations. The
GAPDH derived peptides were able to induce membrane per-
meabilization, enter the cytoplasm of sensitive yeast cells and
trigger apoptosis. Their experiments were conducted on non-
Saccharomyces strains and not on O. oeni strains.
In the present study, the cationic eluate containing the
GAPDH fragments strongly inhibits the malate consumption in
vitro at pH 6.7 (pH of the enzymatic reaction) (Table 4), which
leads us to suggest that the GAPDH peptides may have inhibited
themalolactic enzyme activity by competing for the binding site
of NAD+. In fact, NAD+ is essential for the activation of the en-
zyme. By depriving themalolactic enzyme fromNAD+, it will be-
come dysfunctional. Moreover, the GAPDH fragments may bind
to other parts of the enzyme, thus modifying its conformation
and affecting its function. In vivo, they should enter the bacterial
cytoplasm by mechanisms yet to be identified in order to exert
their inhibitory effect.
Although there is no previous study on the antimicrobial role
of Wtm2p and Utr2p, their fragments seem to play a major role
in the inhibition since the corresponding anionic eluate strongly
inhibited the malolactic enzyme activity in vitro, as previously
shown in Table 4. Giving their pI (3.5 and 4), the peptidic frag-
ments are anionic at pH 6.7 that is the pH of this in vitro experi-
ment. Therefore, they may deprive the malolactic enzyme of its
Mn++ cofactors by chelating them or of NAD+ by binding to it,
thus inhibiting the malolactic enzyme activity and the malate
consumption. Since pH 6.7 is around the cytoplasmic pH ofmost
lactic acid bacteria, we can assume that whenWtm2p and Utr2p
peptidic fragments enter the cytoplasm of O. oeni Vitilactic F in
vivo, they will be able to work similarly, leading to an inhibition
of the MLF.
Moreover, it was previously demonstrated that some AMPs
are able to translocate across membranes and target cytoplas-
mic constituents without disrupting plasma membranes (Park
et al. 2000; Powers and Hancock 2003; Brown and Hancock
2006). Therefore, it would be interesting to see if the peptides
obtained in the current study are able to disrupt the bacte-
rial plasma membrane, or translocate inside the cell without
membrane disruption. The entrance of anionic peptides like
Wtm2p and Utr2p may require some divalent metal cations
like Fe++, Mn++, Mg++, or others. In fact, several studies have
shown that the antimicrobial activity of anionic peptides is en-
hanced by metal cations that promote their binding to the neg-
atively charged components of cell-walls and/or plasma mem-
branes (Dashper et al. 2005; Dashper, Liu and Reynolds 2007). Some
of them are able to translocate across membranes or increase
membrane permeability by forming pores (Harris, Dennison and
Phoenix 2009).
CONCLUSIONS
Saccharomyces cerevisiae Uvaferm BDX was able to release nine
anti-MLF peptides with a MW range between 0.8 and 2.42 kDa.
These peptides derived from eight proteins that play diverse vi-
tal roles in yeast cells. Two GAPDH fragments of 0.9 and 1.373
kDa having a pI of 10.5 and 11 respectively, and fragments of
Wtm2p and Utr2p of 2.42 kDa with a pI of 3.5 and 4 respectively
were thought to contribute themost to the MLF inhibition. How-
ever, it is likely that one or more of the nine peptides worked
synergistically to inhibit MLF. The peptides were able to inhibit
the malolactic enzyme activity in vitro at a pH range between 3.5
and 6.7. In vivo, they are supposed to enter the bacterial cyto-
plasm by mechanisms yet to be identified in order to reach the
malolactic enzyme. It would be interesting for future studies to
synthesize these peptides in order to test them individually in
vivo and in vitro experiments and to evaluate the contribution of
each in the MLF inhibition. It would be also important to evalu-
ate their spectrum of activity against other O. oeni strains, wine
spoilage and pathogenic microorganisms. Studying their inter-
action with the plasma membrane, the mechanisms by which
they enter inside the bacterial cytoplasm and inhibit the malo-
lactic enzyme activity would also be beneficial.
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